• Explore /
  • Poster
  • / A randomized phase II feasibility study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).

A randomized phase II feasibility study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).

Abstract Video & Slides Poster

Authors

null

Francis W. Nugent III

Beth Isreal/Lahey Health, Burlington, MA

Francis W. Nugent III, Klaudia Hunter , Chris Molgaard , Amir Qamar , Krishna Gunturu , Keith E. Stuart , Frederic Gordon , Sebastian Flacke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT02182687

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4586)

DOI

10.1200/JCO.2020.38.15_suppl.4586

Abstract #

4586

Poster Bd #

194

Abstract Disclosures

Similar Posters

First Author: Francis W. Nugent III

First Author: John Nikitas

First Author: Chi Leung Chiang

First Author: Wee Loon Ong